Merck & Company Inc - Capital Expenditures

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Capital-Expenditures" stands at 4.02 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2023.

Merck & Company Inc's third quarter result of 0.987 Billion USD for the item "Capital Expenditures" represents an increase of 29.19 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 0.987 Billion USD for the item "Capital Expenditures" represents an increase of 26.05 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 4.02 Billion USD for the item "Capital Expenditures" represents an increase of 5.35 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 17.29 percent compared to the value the year prior.
The 1 year change in percent is 17.29.
The 3 year change in percent is -9.69.
The 5 year change in percent is -6.76.
The 10 year change in percent is 76.14.

The Serie's long term average value is 2.88 Billion United States Dollars. It's latest available value, on 09/30/2025, is 39.65 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2014, to it's latest available value, on 09/30/2025, is +219.75%.
The Serie's change in percent from it's maximum value, on 06/30/2021, to it's latest available value, on 09/30/2025, is -21.22%.